Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

GH Research PLC (GHRS) vs Stoke Therapeutics, Inc. (STOK)

GH Research PLC and Stoke Therapeutics, Inc. are both Biotechnology companies. GH Research PLC and Stoke Therapeutics, Inc. are of similar size ($1.7B and $1.6B). GH Research PLC has the higher net margin (0.00% vs −753.6%) and the higher return on invested capital (0.00% vs −264.8%). Across the 13 metrics below, GH Research PLC leads on 11 and Stoke Therapeutics, Inc. on 2.

Valuation

Metric GHRS STOK Biotechnology median
P/E n/m n/m 7.88
P/S n/m 59.35 11.47
P/B 4.41 4.74 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 48.73 10.73
Earnings yield (4.19%) (13.59%) (28.84%)
Free cash flow yield (3.27%) (11.04%) (23.03%)

Profitability

Metric GHRS STOK Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (809.69%) 0.00%
Net margin 0.00% (753.60%) 0.00%
Free cash flow margin 0.00% (654.92%) 0.00%
Return on equity (18.79%) (61.10%) (57.72%)
Return on assets (18.16%) (53.41%) (49.22%)
Return on invested capital 0.00% (264.77%) 0.00%

Growth

Metric GHRS STOK Biotechnology median
Revenue growth (TTM) — (86.20%) 5.64%
EPS growth (last fiscal year) (5.33%) 92.73% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GHRS STOK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 28.70 7.69 4.73
Net debt to EBITDA 4.65 14.29 0.96

Dividend

Metric GHRS STOK Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric GHRS STOK Biotechnology median
Market cap 1.68b 1.63b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack